KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $328.6 million.

  • Acadia Pharmaceuticals' Change in Acquisitions & Divestments rose 81.75% to $125.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $499.6 million, marking a year-over-year increase of 55.90%. This contributed to the annual value of $328.6 million for FY2024, which is 23.55% down from last year.
  • As of FY2024, Acadia Pharmaceuticals' Change in Acquisitions & Divestments stood at $328.6 million, which was down 23.55% from $429.8 million recorded in FY2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Change in Acquisitions & Divestments peaked at $540.0 million during FY2020, and registered a low of $328.6 million during FY2024.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $429.8 million (2023), whereas its average is $398.3 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Change in Acquisitions & Divestments soared by 30.46% in 2020 and then fell by 23.55% in 2024.
  • Yearly analysis of 5 years shows Acadia Pharmaceuticals' Change in Acquisitions & Divestments stood at $540.0 million in 2020, then declined by 21.70% to $422.8 million in 2021, then climbed by 3.22% to $436.4 million in 2022, then fell by 1.52% to $429.8 million in 2023, then fell by 23.55% to $328.6 million in 2024.